| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5464632 | SHIONOGI INC | Rapidly disintegratable multiparticular tablet |
Mar, 2013
(11 years ago) | |
| US6106861 | SHIONOGI INC | Multiparticulate tablet disintegrating in less than 40 seconds in the mouth |
Dec, 2017
(6 years ago) | |
Rybix Odt is owned by Shionogi Inc.
Rybix Odt contains Tramadol Hydrochloride.
Rybix Odt has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Rybix Odt are:
- US5464632
- US6106861
Rybix Odt was authorised for market use on 05 May, 2005.
Rybix Odt is available in tablet, orally disintegrating;oral dosage forms.
The generics of Rybix Odt are possible to be released after 05 December, 2017.
Drugs and Companies using TRAMADOL HYDROCHLORIDE ingredient
Market Authorisation Date: 05 May, 2005
Treatment: NA
Dosage: TABLET, ORALLY DISINTEGRATING;ORAL
More Information on Dosage
RYBIX ODT family patents
